年齢によるてんかん患者におけるブリーバラセタムの有効性および忍容性

Detailed bibliographic record

Summary, etc.：: <p>ブリーバラセタム(Brivaracetam: BRV)は，てんかん患者の部分発作(二次性全般化発作を含む)の治療に使用される抗てんかん薬 (antiseizure medications: ASMs) であり，我が国では2024年8月より販売が開始された．本剤は，脳内の神経終末に存在するシナプ...

Holdings of Libraries in Japan

This page shows libraries in Japan other than the National Diet Library that hold the material.

Please contact your local library for information on how to use materials or whether it is possible to request materials from the holding libraries.

other

J-STAGE
Digital
J-STAGE
CiNii Research
Search Service
Digital
You can check the holdings of institutions and databases with which CiNii Research is linked at the site of CiNii Research.
Check the holdings of this book

You can check the details of this material, its authority (keywords that refer to materials on the same subject, author's name, etc.), etc.

Material Type: 記事
Title: 年齢によるてんかん患者におけるブリーバラセタムの有効性および忍容性
Author Heading: 堀倫徳
Publication Date: 2025
Publication Date (W3CDTF): 2025
Periodical title: ファルマシア
No. or year of volume/issue: 61 4
Volume: 61
Issue: 4
Pages: 357-357
Publication date of volume/issue (W3CDTF): 2025
ISSN (Periodical Title): 00148601
ISSN-L (Periodical Title): 00148601
Publication (Periodical Title): The Pharmaceutical Society of Japan
Text Language Code: ja
Subject Heading: ブリーバラセタム
抗てんかん薬
高齢者
Target Audience: 一般
DOI: 10.14894/faruawpsj.61.4_357
https://doi.org/10.14894/faruawpsj.61.4_357
Data Provider (Database): 国立情報学研究所 : CiNii Research
https://cir.nii.ac.jp/
Original Data Provider (Database): Japan Link Center
https://japanlinkcenter.org/top